TCDAQ — Tricida Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $115.13m
Annual cashflow statement for Tricida, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -41.3 | -103 | -177 | -265 | -177 |
| Depreciation | |||||
| Non-Cash Items | -4.82 | 5.19 | 25.3 | 37.3 | 42.2 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 5.37 | 2.15 | 21.1 | -4.57 | -6.12 |
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -40.4 | -94.9 | -130 | -231 | -140 |
| Capital Expenditures | -1 | -0.855 | -1.42 | -1.6 | -0.099 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -36.9 | -147 | -126 | 142 | 64.3 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -37.9 | -148 | -127 | 140 | 64.2 |
| Financing Cash Flow Items | — | -6.56 | -0.921 | 0 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 82.4 | 271 | 238 | 210 | -40.9 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 4.09 | 27.4 | -18.6 | 119 | -117 |